- eMed Population Health has hired Linda Yaccarino, previously CEO of X (previously Twitter), as CEO of our company
- Company provides leading digital health platform focused on GLP-1/GIP-based population health management
eMed Population Health, the most powerful digital platform for GLP-1/GIP driven population health management, announced the appointment of Linda Yaccarino as Chief Executive Officer. Linda was most recently CEO of X (Twitter).
Her appointment is viewed as a defining moment in eMed’s transformation of chronic care. eMed’s goal is to deliver safe, effective, and accessed healthcare. eMed’s platform delivers an end-to-end, digital-first solution, with the goal of scaling health outcomes. Linda has significantly impacted large-scale transformations and is poised to energize eMed’s growth and impact globally.
Linda has years of experience leading innovative, disruptive partnerships to transform industries. Her leadership will help as eMed grows its national and international partnerships with governments and employers, which are bringing to market peptide-based population health in fresh and new way.
The eMed Board of Directors recognized her appointment as a unique opportunity to add to their leadership team of a visionary, hands-on leader with extensive experience in leading complicated digital ecosystems. Her work transforming one of the most complicated digital platforms in the world is expected to have a direct correlation to deliverable in eMed’s next stage of growth and innovation.
Known for her courageous leadership style and strategic mindset, Linda has an outstanding reputation from many verticals as a builder of impactful partnerships, an organizer of scalable organizations, and as a leader of change. Her appointment illustrates eMed’s intent to lead—not just disrupt—the digital healthcare revolution.
Prior to her time at X, Linda was Chairman, Global Advertising and Partnerships at NBCUniversal, where she architected and led a cross-platform, global advertising strategy that became an industry standard. She has consistently related to organizations in hyper-competitive, disruptive environments throughout her career.
When Linda acknowledged joining eMed as the CEO, she made an important statement regarding a need for bold innovation in healthcare:
"Technology has disrupted healthcare, but it has yet to truly transform it. Today, we have an opportunity to leverage technology, data, and lifestyle in bold new ways to connect directly to consumers. Genuine leadership in this space requires fearless tenacity - the willingness to run through walls and innovate the entire industry. eMed can be that transformational force".
eMed's enterprise-grade digital health platform is quickly gaining global acceptance for providing safe, structured and effective access to life-saving therapies, and the organization is growing its market presence, provider network, behavioral health tools, and data intelligence to make an impact on population health at scale.
The platforms fully integrated digital-first health ecosystem features:
- At-home diagnostic testing
- Screening sessions with a proctor
- Physician-guided prescribing
- Continuous patient support, adherence monitoring
These elements are setting a new standard for employee health benefits and government-supported health programs and reinforce eMed's leadership in the innovation of population health.
.jpg "How Symbiosis is Powering Women Entrepreneurs' Success Globally")